These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29320364)

  • 21. Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability.
    Takano T
    Cureus; 2023 Nov; 15(11):e48088. PubMed ID: 38046756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Cardiovascular Risk Optimization Program in People With Schizophrenia: A Pilot Randomized Controlled Clinical Trial.
    Riera-Molist N; Assens-Tauste M; Roura-Poch P; Guimerà-Gallent M; Santos-López JM; Serra-Millas M; Frau-Rosselló N; Gallego-Peña E; Foguet-Boreu Q
    J Psychiatr Pract; 2023 Nov; 29(6):456-468. PubMed ID: 37948170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life Course Perspectives of Aging With Schizophrenia Spectrum Disorders in Psychiatric and Long-Term Care Facilities.
    Walker VG; Harrison TC
    Gerontologist; 2024 May; 64(5):. PubMed ID: 37930229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Exposure to Ambient PM
    Wang Y; Qiu X; Wei Y; Schwartz JD
    J Am Heart Assoc; 2023 Sep; 12(18):e029428. PubMed ID: 37702054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review.
    Sepúlveda-Lizcano L; Arenas-Villamizar VV; Jaimes-Duarte EB; García-Pacheco H; Paredes CS; Bermúdez V; Rivera-Porras D
    Eur J Investig Health Psychol Educ; 2023 Aug; 13(8):1505-1520. PubMed ID: 37623307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Association between Schizophrenia and Cardiovascular Diseases: Insights into the Role of Sigma 1 Receptor.
    Rafcikova J; Novakova M; Stracina T
    Physiol Res; 2023 Jul; 72(Suppl 2):S113-S126. PubMed ID: 37565416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Older age bipolar disorder.
    Beunders AJM; Orhan M; Dols A
    Curr Opin Psychiatry; 2023 Sep; 36(5):397-404. PubMed ID: 37458495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of Shengmai San and Radix puerariae ameliorates depression-like symptoms in diabetic rats at the nexus of PI3K/BDNF/SYN protein expression.
    Ahmed A; Zeng G; Azhar M; Wang F; Wang J; Fan B; Liu X; Jiang D; Wang Q
    Animal Model Exp Med; 2023 Jun; 6(3):211-220. PubMed ID: 37317044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern.
    Fentie D; Yibabie S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):298. PubMed ID: 37312056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term psycho-social impact of the pandemic on people with intellectual disability and their carers.
    Gabrielsson A; Moghaddassian M; Sawhney I; Shardlow S; Tromans S; Bassett P; Shankar R
    Int J Soc Psychiatry; 2023 Nov; 69(7):1781-1789. PubMed ID: 37191298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics.
    Carli M; Weiss F; Grenno G; Ponzini S; Kolachalam S; Vaglini F; Viaggi C; Pardini C; Tidona S; Longoni B; Maggio R; Scarselli M
    Curr Neuropharmacol; 2023; 21(4):935-950. PubMed ID: 36825703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016.
    Lunghi C; Rochette L; Massamba V; Tardif I; Ouali A; Sirois C
    Front Pharmacol; 2023; 14():1080073. PubMed ID: 36825148
    [No Abstract]   [Full Text] [Related]  

  • 33. Time effect on cardiometabolic risk indicators in patients with bipolar disorder: a longitudinal case-control study.
    Najar H; Joas E; Pålsson E; Landén M
    Eur Arch Psychiatry Clin Neurosci; 2023 Aug; 273(5):1191-1200. PubMed ID: 36422678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Evaluation of PLGA Nanoparticle-Loaded Organogel for the Transdermal Delivery of Risperidone.
    Dilawar N; Ur-Rehman T; Shah KU; Fatima H; Alhodaib A
    Gels; 2022 Nov; 8(11):. PubMed ID: 36354616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major depressive disorder (MDD), antidepressants, and uncontrolled hypertension: A report of intraoperative autonomic dysregulation.
    Paraskeva A; Theodosopoulou P
    Saudi J Anaesth; 2022; 16(4):481-484. PubMed ID: 36337405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study.
    Piras M; Ranjbar S; Laaboub N; Grosu C; Gamma F; Plessen KJ; von Gunten A; Conus P; Eap CB
    Schizophr Bull; 2023 Jan; 49(1):24-33. PubMed ID: 36156101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiometabolic Comorbidity Risk in Pediatric Patients With Psychiatric Illnesses: A Case-Control Inpatient Study.
    Dweik H; Kaur J; Jaka S; Faruki F; Shah RP; Amuk Williams OC; Chalia A; Bachu A
    Cureus; 2022 Jun; 14(6):e26326. PubMed ID: 35911267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.
    Paderina DZ; Boiko AS; Pozhidaev IV; Mednova IA; Goncharova AA; Bocharova AV; Fedorenko OY; Kornetova EG; Semke AV; Bokhan NA; Loonen AJM; Ivanova SA
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol: A Naturalistic and Retrospective Study.
    Swoboda MMM; Bartova L; Dremel M; Rabl U; Laggner A; Frey R
    Front Psychiatry; 2022; 13():825546. PubMed ID: 35669269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.
    Fiedorowicz JG; Brown L; Li J; Parikh SV; Dunlop BW; Forester BP; Shelton RC; Thase ME; Macaluso M; Yu K; Greden JF
    Psychopharmacol Bull; 2021 Nov; 51(4):8-30. PubMed ID: 34887596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.